United Therapeutics Corporation Phase 3 ADVANCE OUTCOMES Results Webcast MARCH 2, 2026 Safe Harbor Statement All statements in this presentation are made as of March 2, 2026. We undertake no obligation to publicly update or revise these statements, whether as a result of new information, future events, or otherwise. Statements included in this presentation that are not historical in nature are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-lo ...

Q4 2025 Earnings Conference Call - March 2, 2026 F O R W A R D L O O K I N G S T A T E M E N T S Some of the statements, estimates or projections contained in this presentation are "forward-looking statements" within the meaning of the U.S. federal securities laws intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained, or incorporated by reference, in this presentation, inc ...

4Q & FY 2025 Results 2 March, 2026 1 Disclaimer-Forward-Looking Statements, Key Financial and Operating Metrics and Non-IFRS Measures Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the U.S. federal securities laws, which statements relate to our current expectations and views of future events. In some cases, these forward-looking statements can be identified by words or phrases such as "believe," "may," "might," "will," "expec ...

Phase 1 Results* for SEP-631, a Novel Oral Small Molecule MRGPRX2 Negative Allosteric Modulator (NAM) for Mast Cell-Driven Diseases March 2, 2026 Nasdaq: SEPN *Data presented at the 2026 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting © 2026 SEPTERNA Forward-Looking Statements This presentation contains express or implied forward‐looking statements of Septerna, Inc. (the "Company," "we," or "our") within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. ...

▼ MALIBU BOATS, INC." Acquisition of Saxdor Yachts March 2, 2026 Forward-Looking Statements This presentation includes forward-looking statements las such term is defined in the Private Securities Litication Reform Act of 1995), Forward-looking statements can be identified by such words and phrases as "believes," "anticipates," "intends," "estimates," "may" "will," "should, " continue" and similar expressions, comparable terminology or the negative thereof, and includes statements in this press release rega ...

Disclaimer This presentation has been prepared by Yatsen Holding Limited (the "Company") solely for information purpose. By viewing or accessing the information contained in this material, you hereby acknowledge and agree that no representations, warranties or undertakings, express or implied, are made by the Company or any of its directors, shareholders, employees, agents, affiliates, advisors or representatives as to, and no reliance should be placed upon, the accuracy, fairness, completeness or correctne ...

The Allstate Corporation Raymond James 2026 Institutional Investors Conference Jess Merten, President, Property-Liability 3.2.2026 Forward-looking statements and non-GAAP financial information The Allstate Corporation 2026 PAGE 1 › This presentation contains forward-looking statements and information. › This presentation also contains non-GAAP measures that are denoted with an asterisk (*). › You can find the reconciliation of those measures to GAAP measures within our most recent earnings release, investor ...

United Bankshares, Inc. (UBSI) Investor Presentation March 2, 2026 FORWARD LOOKING STATEMENTS This presentation and statements made by United Bankshares, Inc. ("UBSI") and its management contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Re ...

Sionna Therapeutics On a Mission to Revolutionize the Cystic Fibrosis Treatment Paradigm March 2nd 2026 Disclaimers and forward-looking statements This presentation contains forward-looking statements of Sionna Therapeutics, Inc. ("Sionna", "the Company", "we", "us", or "our") that involve substantial risks and uncertainties. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding our goal of transforming the treatment paradi ...

Investor Presentation March 2026 Forward-Looking Statements This presentation contains statements that are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified by words such as "estimates," "guidance," "expects," "anticipates," "intends," "plans," "believes," "seeks" and similar expressions. Forward-looking statements include information with respect to financial condition, results of operations, business ...